Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27603316 | 0.98 | ACHE (0.30) | ACHE | |
| SCHEMBL17818217 | 0.78 | ACHE (0.33) | ACHE | |
| SCHEMBL11417292 | 0.78 | ACHE (0.33) | ACHE | |
| SCHEMBL27791506 | 0.78 | MAOB (0.31) | — | |
| SCHEMBL27828699 | 0.78 | POLB (0.32) | — | |
| SCHEMBL28725283 | 0.78 | IDO1 (0.35) | ACHEIDO1 | |
| SCHEMBL195811 | 0.78 | S1PR4 (0.33) | — | |
| SCHEMBL9401075 | 0.76 | IDH1 (0.41) | — | |
| SCHEMBL215511 | 0.76 | — | — | |
| SCHEMBL9743951 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7361687-B2 | Arylsulphonamide derivatives and methods of preparing | LABORATOIRES FOURNIER SA (FR) | 2008-04-22 | — | — | US | claimed |
| US-20060084699-A1 | Novel arylsulphonamide derivatives and use thereof as therapeutic agents | LABORATOIRES FOURNIER SA (FR) | 2006-04-20 | — | — | US | claimed |
| CN-100417656-C | Novel Bi compound, its prepn. method and process for prepn. of films | TOSOH CORP (JP) | 2008-09-10 | — | — | CN | disclosed |
| US-6916944-B2 | Bismuth compound, process of producing the same, and process of producing a film | TOSOH CORPORATION (JP) | 2005-07-12 | — | — | US | disclosed |
| CN-1539841-A | Novel Bi compound, its prepn. method and process for prepn. of films | ������������ʽ���� | 2004-10-27 | — | — | CN | disclosed |
| US-20040204483-A1 | Novel bismuth compound, process of producing the same, and process of producing a film | TOSOH CORPORATION | 2004-10-14 | — | — | US | disclosed |
| EP-1466918-A1 | Novel bismuth compounds, process of producing the same, and process of producing a film | Tosoh Corporation (JP) | 2004-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060084699-A1 | Novel arylsulphonamide derivatives and use thereof as therapeutic agents | UGT1A1, UGT2B7, UGT1A6 | ACHE 4862/4885IDO1 2445/4885 |
| US-20040204483-A1 | Novel bismuth compound, process of producing the same, and process of producing a film | APOB, RNF4, SUV39H1 | ACHE 4369/4885IDO1 3415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.